Smartphone-accessible digital therapeutic
KLAVA developed Quitoxil®, a smartphone-accessible digital therapeutic designed to assist individuals in reducing or stopping tobacco use.
Source: LinkedIn company description · Retrieved October 13, 2026
KLAVA works to improve access to evidence-based care for individuals with addictive disorders.
KLAVA collaborates with the Addiction Medicine Department at AP-HP Paul Brousse to advance equitable access to care. KLAVA has concentrated its research efforts on tobacco dependence.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
KLAVA focuses on equitable access to care for patients affected by substance use disorders.
KLAVA developed Quitoxil®, a smartphone-accessible digital therapeutic designed to assist individuals in reducing or stopping tobacco use.
Source: LinkedIn company description · Retrieved October 13, 2026
The program incorporates clinically validated cognitive and behavioral therapies, with tools to identify addiction mechanisms and adopt evidence-based cessation strategies.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026 and September 26, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.